Our findings are in line with the literature, in which upregulation of IRS2 promoted glucose uptake and glycolysis in mammary tumor cells [24] and chronic myelogenous leukemia cells [47]. This evidence concerns the gene IRS2 and chronic myelogenous leukemia, BCR-ABL1 positive.